Fabino Life Sciences Limited IPO

Apply 0
Avoid 0

i. Fabino Life sciences Ltd is engaged in manufacturing, marketing, trading and Packing of pharmaceutical and other wellness focused consumer products.

ii. Their core business is marketing of Pharmaceutical formulation & products in Domestic market through own distribution network and Sales force under own brand name, Getting its Ayurvedic formulations manufactured through Loan Licensing facilities, Packing, Labeling etc. They export wellness and FMCG products like Coffee, Malt powder, Protein powder, Hair shampoo which are marketed by the company.

iii. Currently, the company has over 70 launched and active products available in markets categorized into
(i) Allopathic, (ii) Covid 19, (iii) Food & Wellness, (iv) Herbal, (v) Veterinary, (vi) Multi-Vitamin, segments.

Competitive Strengths:

i. An experienced promoter from the pharmaceutical industry
ii. Diverse product portfolio
iii. More than 70 registrations for trademarks of products
iv. Low debt balance sheet
v. Strong marketing and distribution network

Objects of the Fabino Life Sciences Limited IPO:

The Company proposes to utilize the Net Proceeds from Issue towards funding the following objects 1. Part Repayment of Loans 2. Funding Working capital requirements 3. General Corporate Purpose

Fabino Life Sciences Limited IPO Details:

Open Date: Dec 31 2021
Close Date: Jan 05 2022
Total Shares: 900,000
Face Value: ₹ 10 Per Equity Share
Issue Type: Fixed Price Issue IPO
Issue Size: 3.24 Cr.
Issue Price: ₹ 36 Per Equity Share
Listing At: BSE SME

Promoters And Management:

i. Aditya Mahavir Jain, aged 20 years is the Whole Time Director of the Company. He was appointed on the Board of the Company w.e.f October 18, 2011. He is pursing Bachelors of Arts from the Atlas Skilltech University, Mumbai, Maharashtra. He is also the Head of Digital Marketing and logistics of the company and looks after the Online promotion of the company, Exporting coffee and malt protein, change in supply. He has been previously associated as intern at Food Art Hospitality, RDH Event Management Company, Ancalima Life sciences Private Limited. ii. Arihant Jain, aged 29 years is the Non-Executive Director of the Company. He was appointed on the Board of the company w.e.f December 29, 2020. He has completed his Bachelors of Technology in Information Technology in the year 2014 from ITM University and further completed Master of Business Administration in the year 2016 from The ICFAI Foundation for Higher Education. He was associated with ICICI bank as a Marketing and Research Analysis. He is currently in his family business of Stainless Steel and also engaged in Import of Dry Fruits & Nuts like Almonds, Walnuts, etc. He has an overall experience of over 10 years. iii. Kuldeep Solanki, aged 48 years is the Non-Executive Independent Director of the Company. He has completed Bachelor of Law at Maharshi Dayanand University in the year 1997. He started his own practice as Lawyer named as KS & Company from the year 1998. He has an experience of over 23 years. He was appointed as the Non-Executive Independent Director of the Company on November 12, 2021.

Financials of Fabino Life Sciences Limited IPO:

Particulars (in Lakhs) March-21 March-20 Mar 19
Revenue 305 751 276
Direct Expenses 0 0 3
Purchases 290 225 244
Change in inventory -17.43 463 -61.64
Employee benefit expenses 14 20 30
Other Expenses 11 9 28
Operating profit 7 34 33
OPM % 2% 5% 12%
Finance Cost 0.66 20 29
Depriciation 1.58 1.79 2.52
Other Income 0.17 0.09 0.02
Profit Before tax 4.26 9.91 0.33
Profit After Tax 3.02 6.89 0.01

Recommendation on Fabino Life Sciences Limited IPO:

to be updated

Lead Manager of Fabino Life Sciences Limited IPO:

  1. Aryaman Financial Services Limited

Registrar of Fabino Life Sciences Limited IPO:

  1. Bigshare Services Private Limited

Company Address:

Fabino Life Sciences Limited 105, 1st Floor, Barodia Tower, Plot No 12, D Block Central Market Prashant Vihar, New Delhi 110085 Phone: +91-9883900021 Email: info@fabinolife.com Websitehttps://www.fabinolife.com/

Discussion on Fabino Life Sciences Limited IPO:

Leave a Reply